Peter Hosein, M.D. (IMAGE)

University of Miami Miller School of Medicine

Peter Hosein, M.D.

Caption

“This is a monumental shift in the treatment of pancreas cancer,” said Peter Hosein, M.D., co-leader of Sylvester’s Gastrointestinal Cancer Site Disease Group. “It’s a historic day for pancreatic cancer.”

Credit

Sylvester Comprehensive Cancer Center

Usage Restrictions

Use with attribution

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.